DCOL Center for Clinical Research | Longview, TX

Research site
707 Hollybrook Drive, Suite 501, Longview, Texas, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 62
Status: Active
Trial type: Interventional
Funder type: Industry

Locations recently updated
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: Placebo for Budigalimab

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing re...

Active, not recruiting
Drug: Optimized Background Regimen (OBR)
Drug: Failing ARV Regimen

Trial conditions

HIV Infections (16 trials)
Acquired Immunodeficienc... (6 trials)
Immunologic Deficiency S... (5 trials)
Constipation (4 trials)
Respiratory Tract Infect... (3 trials)
Fibrosis (2 trials)
Gastrointestinal Diseases (2 trials)
Idiopathic Pulmonary Fib... (2 trials)
Infections (2 trials)
Intestinal Diseases (2 trials)

And 20 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems